Sage Journals: Discover world-class research

Retricted access

Other

First published 2003-10

Therapy with 188 Re-Labeled Radiopharmaceuticals: An Overview of Promising Results from Initial Clinical Trials

Jae Min Jeong, June-Key Chung

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2010-02

Biologic Evaluation of a Novel 188 Re-Labeled Porphyrin in Mice Tumor Model

Haladhar D. Sarma, Tapas Das, Sharmila Banerjee [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2011-10

Chemoradionuclide Therapy with 186 Re-Labeled Liposomal Doxorubicin: Toxicity,Dosimetry,and Therapeutic Response

Anuradha Soundararajan, Ande Bao, William T. Phillips [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Book review

First published 2024-11

Re-labeling the underclass

Hilary Silver

Dialogues in Human Geography

Retricted access

Research article

First published 1997-02

Purification by Affinity Chromatography with Anti-idiotypic Monoclonal Antibodies of Immunoreactive Monoclonal Antibodies Following Labeling with 188 Re

Carl V. Hamby, Marco Chinol, Ciro Manzo [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Retricted access

Research article

First published 2011-12

Imaging,Autoradiography,and Biodistribution of 188 Re-Labeled PEGylated Nanoliposome in Orthotopic Glioma Bearing Rat Model

Feng-Yun J. Huang, Te-Wei Lee, Chih-Hao K. Kao [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1996-04

186 Re-Labeled Antibodies to p185 HER2 as HER2-Targeted Radioimmunopharmaceutical Agents: Comparison of Physical and Biological Characteristics with 125 I and 131 I-Labeled Counterparts

C.E. Kotts, F.M. Su, C. Leddy [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2003-08

Biodistribution of 131 I-,186 Re-,177 Lu-,and 88 Y-Labeled hLL2 (Epratuzumab) in Nude Mice with CD22-Positive Lymphoma

Ernst J. Postema, Cathelijne Frielink, Wim J.G. Oyen [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2004-12

Safety,Pharmacokinetics,Immunogenicity,and Biodistribution of 186 Re-Labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab( in Patients with Early-Stage Breast Cancer

Manuel Koppe, Frank van Schaijk, Jan Roos [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1998-04

Tumor Retention of 186 Re-MAG3,111 In-DTPA and 125 I Labeled Monoclonal Antibody G250 in Nude Mice with Renal Cell Carcinoma Xenografts

M.G. Steffens, M.H.G.C. Kranenborg, O.C. Boerman [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results